Humana Price Target Raised to $220

Truist Financial increases Humana's price target by $20

Apr. 13, 2026 at 1:37pm

Got story updates? Submit your updates here. ›

A high-contrast, cinematic close-up of the heavy, metallic gears and mechanisms that make up the internal components of a large banking vault, conveying a sense of financial security and institutional power.An extreme close-up of the intricate inner workings of a banking vault highlights the tangible, industrial nature of financial infrastructure.Louisville Today

Truist Financial has increased its price target for Humana (NYSE:HUM) from $200.00 to $220.00, while maintaining a 'hold' rating on the insurance provider's stock. This new price target represents a potential upside of 15.59% from the company's current trading price.

Why it matters

This price target increase suggests that analysts see potential upside in Humana's stock, even as they maintain a 'hold' rating. It reflects the ongoing evaluation of the company's performance and outlook by the financial community.

The details

In a research report issued on Monday, Truist Financial analysts raised their price target on Humana from $200.00 to $220.00. The firm currently has a 'hold' rating on the stock. Several other research firms have also weighed in on Humana recently, with some upgrading the stock while others have maintained neutral ratings.

  • Truist Financial issued the updated price target and rating on Monday, April 13, 2026.

The players

Truist Financial

A major U.S. financial services company that provides banking, investing, and mortgage products.

Humana

A leading health insurance and well-being company headquartered in Louisville, Kentucky that primarily serves individuals and groups across the United States.

Got photos? Submit your photos here. ›

What’s next

Investors will be watching to see if Humana's stock price responds positively to the increased price target from Truist Financial. The company's next earnings report will also be closely monitored for signs of continued performance.

The takeaway

This price target increase reflects ongoing Wall Street analysis of Humana's business and outlook. While the 'hold' rating suggests limited near-term upside, the higher target indicates potential for the stock to rise if the company can deliver on expectations.